Shravan Kumar Sriraman
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery 6
- Pharmaceutical Science top 10%
-
- Nanoplatforms for cancer theranostics 4
-
- RNA Interference and Gene Delivery 3
- Lipid Membrane Structure and Behavior 2
- Cell death mechanisms and regulation 1
-
- Virus-based gene therapy research 1
-
- Biomedical Ethics and Regulation 1
-
- Medical Malpractice and Liability Issues 1
- Co-authors
- Vladimir P. TorchilinBhawani AryasomayajulaCan SarısözenEd LutherSwati BiswasGemma NavarroRupa R. SawantYilin Zhang
- Partner nations
- United StatesSaudi ArabiaPoland
In The Last Decade
Shravan Kumar Sriraman
10 papers receiving 591 citations
Peers
Comparison fields: 5 of 84
- Biomaterials 289
- Pharmaceutical Science 36
- Biomedical Engineering 234
- Molecular Biology 321
- Oncology 94
Countries citing papers authored by Shravan Kumar Sriraman
This map shows the geographic impact of Shravan Kumar Sriraman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shravan Kumar Sriraman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shravan Kumar Sriraman more than expected).
Fields of papers citing papers by Shravan Kumar Sriraman
This network shows the impact of papers produced by Shravan Kumar Sriraman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shravan Kumar Sriraman. The network helps show where Shravan Kumar Sriraman may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Shravan Kumar Sriraman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2022 | 15 | |
| 3 | 2016 | 84 | |
| 4 | 2016 | 59 | |
| 5 | 2015 | 18 | |
| 6 | 2015 | 44 | |
| 7 | 2015 | 50 | |
| 8 | 2015 | 1 | |
| 9 | 2014 | 245 | |
| 10 | 2012 | 85 |
About Shravan Kumar Sriraman
Shravan Kumar Sriraman is a scholar working on Biomaterials, Pharmacy and Reproductive Medicine, having authored 10 papers that have together received 602 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (6 papers), Nanoplatforms for cancer theranostics (4 papers), RNA Interference and Gene Delivery (3 papers), Lipid Membrane Structure and Behavior (2 papers), Cell death mechanisms and regulation (1 paper), Virus-based gene therapy research (1 paper), Biomedical Ethics and Regulation (1 paper) and Medical Malpractice and Liability Issues (1 paper). The work is most often cited by research in Biomaterials (289 citations), Pharmaceutical Science (36 citations) and Biomedical Engineering (234 citations). Shravan Kumar Sriraman has collaborated with scholars based in United States, Saudi Arabia and Poland. Frequent co-authors include Vladimir P. Torchilin, Bhawani Aryasomayajula, Vladimir P. Torchilin, Can Sarısözen, Ed Luther, Swati Biswas, Gemma Navarro, Rupa R. Sawant, Yilin Zhang and Jiayi Pan. Their work appears in journals such as Biomaterials, Cancer Research and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.